NEW YORK (GenomeWeb News) – The Baylor College of Medicine's Medical Genetics Laboratories will use Illumina's Infinium High-Density DNA Analysis products in genomic studies of developmental disorders.
Specifically, the Houston-based lab intends to use Illumina's arrays for studying genomic imprinting and its role in developmental diseases such as Prader-Willi syndrome, Angelman syndrome, and other disorders caused by uniparental disomy.
"Results from early tests show that we can quickly generate high-quality data using Illumina's SNP arrays, providing us with the information required to more rapidly and accurately identify causative aberrations in the genome," said Arthur Beaudet, chair of the department of molecular and human genetics at Baylor college of Medicine, in a statement.